^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

RUNX1-RUNX1T1 fusion

i
Other names: RUNX1, RUNX Family Transcription Factor 1, Runt-Related Transcription Factor 1, Polyomavirus Enhancer-Binding Protein 2 Alpha B Subunit, SL3/AKV Core-Binding Factor Alpha B Subunit, SL3-3 Enhancer Factor 1 Alpha B Subunit, Runt Related Transcription Factor 1, Acute Myeloid Leukemia 1 Protein, Oncogene AML-1, PEBP2-Alpha B, PEA2-Alpha B, AMLCR1, CBFA2, AML1, Core-Binding Factor Subunit Alpha-2, AML1-EVI-1 Fusion Protein, Acute Myeloid Leukemia 1, Aml1 Oncogene, CBF-Alpha-2, AML1-EVI-1, PEBP2alpha
Entrez ID:
Related biomarkers:
Phase 3
University of Ulm
Completed
Last update posted :
02/23/2024
Initiation :
07/01/2014
Primary completion :
02/01/2024
Completion :
02/01/2024
RUNX1 • RUNX1T1
|
RUNX1-RUNX1T1 fusion • CBFB-MYH11 fusion
|
dasatinib • daunorubicin • idarubicin hydrochloride
Phase N/A
Acute Leukemia French Association
Completed
Last update posted :
01/31/2024
Initiation :
09/22/2021
Primary completion :
01/25/2024
Completion :
01/25/2024
RUNX1 • RUNX1T1
|
RUNX1-RUNX1T1 fusion • CBFB-MYH11 fusion
Phase 2
National Cancer Institute (NCI)
Completed
Last update posted :
03/01/2023
Initiation :
12/14/2010
Primary completion :
07/01/2013
Completion :
03/15/2021
RUNX1 • RUNX1T1
|
RUNX1-RUNX1T1 fusion • CBFB-MYH11 fusion
|
dasatinib • cytarabine • daunorubicin • Starasid (cytarabine ocfosfate)
Phase 1/2
University of Ulm
Completed
Last update posted :
03/01/2016
Initiation :
06/01/2009
Primary completion :
11/01/2015
Completion :
11/01/2015
RUNX1 • RUNX1T1
|
RUNX1-RUNX1T1 fusion • CBFB-MYH11 fusion
|
dasatinib • cytarabine • daunorubicin